Montelukast

CAS 158966-92-8 3 current recordsSmall Molecule

Who holds supplier records for Montelukast? 3 organisations hold a current record for Montelukast: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Canada (1), China (1) and United States (1).

Most records are filed under another form of this substance: Montelukast Sodium (21 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Montelukast: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/montelukast

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Montelukast. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Montelukast sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Montelukast is a leukotriene receptor antagonist that is used for the treatment of asthma and allergic rhinitis. It works by blocking substances in the body called leukotrienes, which cause asthma and allergy symptoms.

Chemical identity

IUPAC name
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
Canonical SMILES
CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O
InChIKey
UCHDWCPVSPXUMX-TZIWLTJVSA-N
Synonyms
brondilat

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Leukotriene Receptor Antagonist
Mechanism of action
Leukotriene Receptor Antagonists

Therapeutic areas

RespiratoryAllergyInflammation

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Montelukast?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Montelukast: DELMAR CHEMICALS INC (Canada), JIANGSU ALPHA GROUP SHENGJI PHARMACEUTICAL (SUQIAN) CO LTD (China) and NENTER AND CO INC (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Montelukast Drug Master Files are active?

DELMAR CHEMICALS INC (DMF 16243), JIANGSU ALPHA GROUP SHENGJI PHARMACEUTICAL (SUQIAN) CO LTD (DMF 41820) and NENTER AND CO INC (DMF 30521). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Montelukast supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Montelukast?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.